Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1989 1
1991 1
1993 1
1995 1
1997 3
1999 2
2000 4
2001 1
2003 1
2004 1
2005 2
2006 1
2007 1
2008 1
2009 2
2011 1
2012 1
2013 1
2014 5
2015 4
2016 4
2017 7
2018 6
2019 10
2020 8
2021 7
2022 5
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Grade 3 Bronchopulmonary Dysplasia, AE"
Page 1
Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children.
Garegnani L, Styrmisdóttir L, Roson Rodriguez P, Escobar Liquitay CM, Esteban I, Franco JV. Garegnani L, et al. Cochrane Database Syst Rev. 2021 Nov 16;11(11):CD013757. doi: 10.1002/14651858.CD013757.pub2. Cochrane Database Syst Rev. 2021. PMID: 34783356 Free PMC article. Review.
Two review authors screened studies for selection, assessed risk of bias and extracted data. We used standard Cochrane methods. We used GRADE to assess the certainty of the evidence. The primary outcomes were hospitalisation due to RSV infection, all-cause mortality and …
Two review authors screened studies for selection, assessed risk of bias and extracted data. We used standard Cochrane methods. We used G …
Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants.
Subramaniam P, Ho JJ, Davis PG. Subramaniam P, et al. Cochrane Database Syst Rev. 2021 Oct 18;10(10):CD001243. doi: 10.1002/14651858.CD001243.pub4. Cochrane Database Syst Rev. 2021. PMID: 34661278 Free PMC article. Review.
OBJECTIVES: To determine if prophylactic nasal CPAP (started within the first 15 minutes) or very early nasal CPAP regardless of respiratory status (started within the first hour of life), reduces the use of mechanical ventilation and the incidence of bronchopulmonary d …
OBJECTIVES: To determine if prophylactic nasal CPAP (started within the first 15 minutes) or very early nasal CPAP regardless of respiratory …
Continuous positive airway pressure (CPAP) for respiratory distress in preterm infants.
Ho JJ, Subramaniam P, Davis PG. Ho JJ, et al. Cochrane Database Syst Rev. 2020 Oct 15;10(10):CD002271. doi: 10.1002/14651858.CD002271.pub3. Cochrane Database Syst Rev. 2020. PMID: 33058208 Free PMC article.
DATA COLLECTION AND ANALYSIS: We used standard methods of Cochrane and its Neonatal Review Group, including independent assessment of risk of bias and extraction of data by two review authors. We used the GRADE approach to assess the certainty of evidence. Subgroup analyse …
DATA COLLECTION AND ANALYSIS: We used standard methods of Cochrane and its Neonatal Review Group, including independent assessment of risk o …
17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial.
Blackwell SC, Gyamfi-Bannerman C, Biggio JR Jr, Chauhan SP, Hughes BL, Louis JM, Manuck TA, Miller HS, Das AF, Saade GR, Nielsen P, Baker J, Yuzko OM, Reznichenko GI, Reznichenko NY, Pekarev O, Tatarova N, Gudeman J, Birch R, Jozwiakowski MJ, Duncan M, Williams L, Krop J. Blackwell SC, et al. Am J Perinatol. 2020 Jan;37(2):127-136. doi: 10.1055/s-0039-3400227. Epub 2019 Oct 25. Am J Perinatol. 2020. PMID: 31652479 Free article. Clinical Trial.
The composite included any of the following: neonatal death, grade 3 or 4 intraventricular hemorrhage, respiratory distress syndrome, bronchopulmonary dysplasia, necrotizing enterocolitis, or proven sepsis. ...
The composite included any of the following: neonatal death, grade 3 or 4 intraventricular hemorrhage, respiratory distress sy …
Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews.
van de Loo M, van Kaam A, Offringa M, Doyle LW, Cooper C, Onland W. van de Loo M, et al. Cochrane Database Syst Rev. 2024 Apr 10;4(4):CD013271. doi: 10.1002/14651858.CD013271.pub2. Cochrane Database Syst Rev. 2024. PMID: 38597338 Review.
BACKGROUND: Bronchopulmonary dysplasia (BPD) remains an important complication of prematurity. ...No evidence of harmful effects was found. There was little evidence for effects of different starting doses or timing of systemic corticosteroids on death …
BACKGROUND: Bronchopulmonary dysplasia (BPD) remains an important complication of prematurity. ...No evidence of harmful ef …
Inhaled Corticosteroids for Bronchopulmonary Dysplasia: A Meta-analysis.
Shinwell ES, Portnov I, Meerpohl JJ, Karen T, Bassler D. Shinwell ES, et al. Pediatrics. 2016 Dec;138(6):e20162511. doi: 10.1542/peds.2016-2511. Pediatrics. 2016. PMID: 27940717 Review.
CONTEXT: Bronchopulmonary dysplasia (BPD) in preterm infants remains a major health burden despite many therapeutic interventions. ...STUDY SELECTION: Randomized controlled trials of ICs versus placebo for either prevention or treatment of BPD. DATA EXTRACTION: This …
CONTEXT: Bronchopulmonary dysplasia (BPD) in preterm infants remains a major health burden despite many therapeutic interventi …
Retinopathy of Prematurity: Therapeutic Strategies Based on Pathophysiology.
Cayabyab R, Ramanathan R. Cayabyab R, et al. Neonatology. 2016;109(4):369-76. doi: 10.1159/000444901. Epub 2016 Jun 3. Neonatology. 2016. PMID: 27251645 Review.
Most of the large trials have focused on either a low SpO2 (85-89%) or a high SpO2 (91-95%) from the first day of birth to 36 weeks' PMA. Although the incidence of severe ROP and bronchopulmonary dysplasia decreased significantly, predischarge mortality was higher i …
Most of the large trials have focused on either a low SpO2 (85-89%) or a high SpO2 (91-95%) from the first day of birth to 36 weeks' PMA. Al …
Late ( 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
Onland W, Offringa M, van Kaam A. Onland W, et al. Cochrane Database Syst Rev. 2022 Dec 15;12(12):CD002311. doi: 10.1002/14651858.CD002311.pub5. Cochrane Database Syst Rev. 2022. PMID: 36521169 Free PMC article. Review.
BACKGROUND: Bronchopulmonary dysplasia (BPD), defined as oxygen dependence at 36 weeks' postmenstrual age (PMA), remains an important complication of prematurity. ...Secondary outcomes included short-term respiratory outcomes (mortality or BPD at 28 days' PNA, failu …
BACKGROUND: Bronchopulmonary dysplasia (BPD), defined as oxygen dependence at 36 weeks' postmenstrual age (PMA), remains an im …
Inhaled nitric oxide for respiratory failure in preterm infants.
Barrington KJ, Finer N, Pennaforte T. Barrington KJ, et al. Cochrane Database Syst Rev. 2017 Jan 3;1(1):CD000509. doi: 10.1002/14651858.CD000509.pub5. Cochrane Database Syst Rev. 2017. PMID: 28045472 Free PMC article. Review.
The pathophysiology of respiratory failure and the potential risks of iNO differ substantially in preterm infants, necessitating specific study in this population. OBJECTIVES: To determine effects of treatment with inhaled nitric oxide (iNO) on death, bronchopulmonary …
The pathophysiology of respiratory failure and the potential risks of iNO differ substantially in preterm infants, necessitating specific st …
High versus standard dose caffeine for apnoea: a systematic review.
Vliegenthart R, Miedema M, Hutten GJ, van Kaam AH, Onland W. Vliegenthart R, et al. Arch Dis Child Fetal Neonatal Ed. 2018 Nov;103(6):F523-F529. doi: 10.1136/archdischild-2017-313556. Epub 2018 Feb 7. Arch Dis Child Fetal Neonatal Ed. 2018. PMID: 29437799 Review.
BACKGROUND: Placebo-controlled trials have shown that caffeine is highly effective in treating apnoea of prematurity and reduces the risk of bronchopulmonary dysplasia (BPD) and neurodevelopmental impairment (NDI). ...The quality of the outcome measures were deemed …
BACKGROUND: Placebo-controlled trials have shown that caffeine is highly effective in treating apnoea of prematurity and reduces the risk of …
85 results